Authors:
HOPFNER KP
KOPETZKI E
KRESSE GB
BODE W
HUBER R
ENGH RA
Citation: Kp. Hopfner et al., NEW ENZYME LINEAGES BY SUBDOMAIN SHUFFLING, Proceedings of the National Academy of Sciences of the United Statesof America, 95(17), 1998, pp. 9813-9818
Authors:
STURZEBECHER J
PRASA D
KOPETZKI E
HOPFNER KP
SVENDSEN L
WICKSTROM P
Citation: J. Sturzebecher et al., DETERMINATION OF COAGULATION-FACTOR IXA USING CHROMOGENIC OR FLUOROGENIC SUBSTRATES, Thrombosis and haemostasis, 1997, pp. 2541-2541
Authors:
HOPFNER KP
BRANDSTETTER H
KARCHER A
KOPETZKI E
HUBER R
ENGH RA
BODE W
Citation: Kp. Hopfner et al., CONVERTING BLOOD-COAGULATION FACTOR IXA INTO FACTOR XA - DRAMATIC INCREASE IN AMIDOLYTIC ACTIVITY IDENTIFIES IMPORTANT ACTIVE-SITE DETERMINANTS, EMBO journal, 16(22), 1997, pp. 6626-6635
Authors:
STURZEBECHER J
KOPETZKI E
BODE W
HOPFNER KP
Citation: J. Sturzebecher et al., DRAMATIC ENHANCEMENT OF THE CATALYTIC ACTIVITY OF COAGULATION-FACTOR IXA BY ALCOHOLS, FEBS letters, 412(2), 1997, pp. 295-300
Authors:
STEMPFER G
HOLLNEUGEBAUER B
KOPETZKI E
RUDOLPH R
Citation: G. Stempfer et al., A FUSION PROTEIN DESIGNED FOR NONCOVALENT IMMOBILIZATION - STABILITY,ENZYMATIC-ACTIVITY, AND USE IN AN ENZYME REACTOR, Nature biotechnology, 14(4), 1996, pp. 481-484
Authors:
BORGYA A
WOODMAN A
SUGIYAMA M
DONIE F
KOPETZKI E
MATSUMURA Y
TARIN D
Citation: A. Borgya et al., ISOLATION AND CHARACTERIZATION OF ANTIBODIES WHICH SPECIFICALLY RECOGNIZE THE PEPTIDE ENCODED BY EXON-7 (V2) OF THE HUMAN CD44 GENE, JCP. Clinical molecular pathology, 48(5), 1995, pp. 241-250
Authors:
LEHLE L
EIDEN A
LEHNERT K
HASELBECK A
KOPETZKI E
Citation: L. Lehle et al., GLYCOPROTEIN-BIOSYNTHESIS IN SACCHAROMYCES-CEREVISIAE - NGD29, AN N-GLYCOSYLATION MUTANT ALLELIC TO OCH1 HAVING A DEFECT IN THE INITIATION OF OUTER CHAIN FORMATION, FEBS letters, 370(1-2), 1995, pp. 41-45
Citation: E. Kopetzki et al., ENZYMES IN DIAGNOSTICS - ACHIEVEMENTS AND POSSIBILITIES OF RECOMBINANT-DNA TECHNOLOGY, Clinical chemistry, 40(5), 1994, pp. 688-704